Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy

AIDS

Volumn 13, Issue 8, 1999, Pages 951-956

  Staszewski, Schlomo ^a   Miller, Veronica ^a   Sabin, Caroline ^c   Schlecht, Christine ^a   Gute, Peter ^a   Stamm, Silke ^a   Leder, Thomas ^a   Berger, Annemarie ^a   Weidemann, Eckhart ^a   Hill, Andrew ^b   Phillips, Andrew ^c  

^a GOETHE UNIVERSITY   (Germany)

^b GLAXOSMITHKLINE   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Antiretroviral therapy; CD4 counts; Indinavir; Viral replication

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; INDINAVIR; VIRUS RNA;

ADULT; ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DRUG THERAPY, COMBINATION; FEMALE; HIV; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0032968454     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199905280-00011     Document Type: Article

References (32)

1. Lane HC, Masur H, Gelmann EP, et al. Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. Am J Med 1985, 78:417-422.
2. Phillips AN, Lee CA, Elford J, et al. Serial CD4 lymphocyte counts and the development of AIDS. Lancet 1991, 337:389-392.
3. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
4. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4+ Tcell counts of 200 per cubic millimeter or less. N Engl J Med 1997, 337:725-733.
5. Gullick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997, 337:734-739.
6. Markowitz M, Saag M, Powderly WG, et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med 1995, 333:1534-1539.
7. Danner SA, Carr A, Leonord JM, et al. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. N Engl J Med 1995, 333:1528-1533.
8. Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced disease. Science 1997, 277:112-116.
9. Li TS, Tubiana R, Katlama C, Calvez V, Ait Hohand H, Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroiviral therapy in advanced HIV-1 disease. Lancet 1998, 351:1682-1686.
10. Sprent J, Tough D. HIV results in the frame: antiretroviral therapy. Nature 1995, 375:193.
11. Dimitrov DS, Martin MA. HIV results in the frame: antiretroviral therapy. Nature 1995, 375:194-195.
12. Phillips AN, Sabin CA, Mocroft A, Janossy G. HIV Results in the frame: antiretroviral therapy. Nature 1995, 375:195.
13. Lafeuillade A, Chouraqui M, Hiltinger G, Poggi C, Delbeke E. Lymph node expansion of CD4+ lymphocytes during antiretroviral therapy. J Infect Dis 1997, 176:1378-1382.
14. Pakker NG, Notermans DW, de Boer RJ, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 1998, 4:208-214.
15. Bofill M, Janossy G, Lee CA, et al. Laboratory control values for CD4 and CD8 T lymphocyte implications for HIV-1 diagnosis. Clin Exp Immunol 1992, 88:243.
16. Maini MK, Gilson RJ, Chavda N, et al. Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin Med 1996, 72:27-31.
17. SAS Institute Inc. SAS/STAT users guide, version 6.12. Cary NC: SAS Institute Inc.; 1996.
18. Mackall CL, Hakim FT, Gress RE, et al. T-cell regeneration: all repertoires are not created equal. Immunol Today 1997, 18:245-251.
19. Douek DC, McFarland RD, Keiser PH, et al. Changes in the thymic function with age during treatment of HIV infection. Nature 1998, 396:690-695.
20. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995, 332:143-149.
21. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
22. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
23. Hughes MD, Johnson VA, Hirsch MS, et al. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. Ann Intern Med 1997, 126:929-938.
24. Mohri H, Bonhoeffer S, Monard S, Perelson AS, Ho DD. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 1998, 279:1223-1227.
25. Cohen J. Failure isn't what it used to be ... but neither is success. Science 1998, 279:1133-1134.
26. Roederer M. Getting to the HAART of T cell dynamics. Nat Med 1998, 4:145-146.
27. Kaufmann D, Pantaleo G, Sudre P, Telenti A. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy. Lancet 1998, 351:723-724.
28. Moreland LW, Bucy RP, Keepman WJ. Regeneration of T cells after chemotherapy. N Engl J Med 1995, 332:1651-1652.
29. Carr A, Emery S, Kelleher A, Law M, Cooper DA. CD8 lymphocyte responses to antiretroviral therapy of HIV infection. J Aquir Immune Defic Syndr 1996, 13:320-326.
30. Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996, 173:321-329.
31. Phillips AN, McLean AR, Loveday C, et al. In vivo HIV-1 replicative capacity in early and advanced infection. AIDS 1999, 13:67-73.
32. Phillips AN, McLean A, Johnson MA, et al. HIV-1 dynamics after transient antiretroviral therapy: implications for pathogenesis and clinical management. J Med Virol 1997, 53:261-265.